ET-01 in Subjects With Lateral Canthal Lines, LCL-210

NCT04985916 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

280

Enrollment

INDUSTRY

Sponsor class

Conditions

Lateral Canthal Lines, LCL
Crow's Feet

Interventions

BIOLOGICAL: Vehicle
BIOLOGICAL: botulinum toxin, Type A

Sponsor

Eirion Therapeutics Inc.